Skip to main content
Premium Trial:

Request an Annual Quote

John Vuko, Barry Honig, Andrew DePristo, and Wolfgang Gentzsch

Premium

John Vuko, formerly executive vice president and chief financial officer at Incyte, has joined Genitope as vice president of finance and chief financial officer. He will lead the company’s finance, legal, and IT functions.


Barry Honig was among 72 new members elected by the National Academy of Sciences last week. Honig is an investigator at the Howard Hughes Medical Institute, a professor in the department of biochemistry and molecular biophysics at Columbia University, and is affiliated with Columbia’s Center for Computational Biology and Bioinformatics.


Cheminformatics company Bioreason has appointed Andrew DePristo as president and CEO. DePristo was most recently senior director of research and preclinical development information systems at Amgen. Prior to that, he was the founding president of GeneData’s US subsidiary; and vice president of bioinformatics, information technology, and emerging technology at Genome Therapeutics.


MCNC, the non-profit technology development organization responsible for the North Carolinna BioGrid and other statewide computing initiatives, has hired Wolfgang Gentzsch to lead its grid computing initiatives as managing director of its Grid Computing and Networking Services unit. Gentzsch was most recently senior director of grid computing for Sun Microsystems.

Filed under

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.